Business Context and Reporting Period
Company: West Pharmaceutical Services, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2026
Reporting Period: First Quarter 2026
This filing announces the Company's first-quarter 2026 financial results and includes Regulation FD disclosure regarding the press release and investor presentation materials.
Key Financial Metrics
The provided text serves as a cover document referencing the press release (Exhibit 99.1) and presentation (Exhibit 99.2). The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached exhibits for detailed financial data.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Such details are contained within the referenced press release and presentation materials.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release and presentation materials on April 23, 2026, which are incorporated by reference.
Availability: Presentation materials are available via the Investors link at the Company's website (http://www.westpharma.com).
Legal Status: The information furnished in this report and its exhibits is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, except as expressly referenced in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, earnings, and margin figures.
- Examine Exhibit 99.2 (Presentation) for management's outlook, guidance, and strategic commentary.
- Verify the Company's website for the latest investor presentation materials referenced in Item 7.01.
- Confirm that the financial data in the press release aligns with the Company's historical reporting trends.